Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Group G/C Streptococcus Infections during Labour and Postpartum (POGSI)
2024-519263-18-00Phase 4Authorised
- Sponsor
- University of Oulu
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of benzylpenicillin and clindamycin in Group G Streptococcal Infection, Group C Streptococcal Infection and Infection (2 arms), sponsored by University of Oulu. Primary endpoint: Maternal postpartum infection requiring antibiotics. Planned start Nov 2024; status: authorised.
02
Drugs
benzylpenicillinclindamycin
03
Conditions
Group G Streptococcal InfectionGroup C Streptococcal InfectionInfection
Beyond the preview
Go deeper on 2024-519263-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519263-18-00.